Category Archives: Pharmaceuticals

All three of the world’s major drug regulators have busy week despite heat waves, political chaos. You know; the usual.

Last week was a rare case where the world’s leading drugs and devices regulators were all in action simultaneously. The US Food and Drug Administration (FDA), the European Medicines Agency… Read more »

Pace of health-sector IPO action finally slows, but deal sizes grow, proving lots of cash still parked on the sidelines.

Three tech companies in the health sector entered the public market last week, raising a total of $601 million. Here are the proud IPOs and a glance at this week’s… Read more »

July’s IPO action in health sector foreshadows record month of pricings.

The second week of July continued the stampede among healthcare startups and seasoned players in search of new funding from Wall Street and, in one case, the Hong Kong exchange…. Read more »

European drug regulator comes out of hibernation in new Dutch headquarters, rivaling the FDA with rulings; well, just for one week.

It may have taken nearly 6 months and perhaps a Fourth of July holiday-shortened work week here in the US, but the European Medicines Agency (EMA) finally issued some new… Read more »

BioNTech raises $325M in Series B round, skipping IPO for now

The News: Germany’s BioNTech raises eye-popping €290M ($325M) in Series B round to fund personalized mRNA cancer vaccines, eschewing IPO for now. Just where does German biotech stand vis-à-vis the… Read more »

Healthcare IPOs lead 2Q19 to 5-year record.

During the second quarter ending June 30, 62 IPOs raised $25.0 billion, the most active quarter by deal count in four years and the most capital raised in five years…. Read more »

Brexit referendum slowing the European Medicines Agency’s operations to a crawl.

The News: The European Medicines Agency (EMA) recently addressed its concerns for ensuring business continuity and staff retention which had become huge challenges caused by the Brexit referendum. The EMA… Read more »

Investors shell out $619M in huge health-sector IPO stampede.

The News: Four biotechs and a genome-sequencing player firm grabbed their brass rings last week, cashing in with $619 million in total IPO funding. That means that with one week… Read more »